Choosing preclinical study models of diabetic retinopathy: key problems for consideration
Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo a...
Saved in:
Published in | Drug design, development and therapy Vol. 8; no. default; pp. 2311 - 2319 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2014
Taylor & Francis Ltd Dove Press Dove Medical Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. |
---|---|
AbstractList | Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. Xue-Song Mi,1,2 Ti-Fei Yuan,3,4 Yong Ding,1 Jing-Xiang Zhong,1 Kwok-Fai So4,5 1Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China; 2Department of Anatomy, Li Ka Shing Faculty ofMedicine, The University of Hong Kong, Hong Kong, People's Republic ofChina; 3School of Psychology, Nanjing Normal University, Nanjing, People's Republic of China; 4Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; 5Guangdong-Hongkong-Macau Institute of Central Nervous System, Jinan University, Guangzhou, People's Republic of China Abstract: Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. Keywords: animal model, in vitro culture, ex vivo culture, neurovascular dysfunction Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. Keywords: animal model, in vitro culture, ex vivo culture, neurovascular dysfunction Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR.Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. |
Audience | Academic |
Author | Zhong, Jing-Xiang Ding, Yong So, Kwok-Fai Yuan, Ti-Fei Mi, Xuesong |
AuthorAffiliation | 4 Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 5 Guangdong-Hongkong-Macau Institute of Central Nervous System, Jinan University, Guangzhou, People’s Republic of China 2 Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China 1 Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People’s Republic of China 3 School of Psychology, Nanjing Normal University, Nanjing, People’s Republic of China |
AuthorAffiliation_xml | – name: 4 Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong – name: 1 Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People’s Republic of China – name: 3 School of Psychology, Nanjing Normal University, Nanjing, People’s Republic of China – name: 2 Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China – name: 5 Guangdong-Hongkong-Macau Institute of Central Nervous System, Jinan University, Guangzhou, People’s Republic of China |
Author_xml | – sequence: 1 givenname: Xuesong surname: Mi fullname: Mi, Xuesong – sequence: 2 givenname: Ti-Fei surname: Yuan fullname: Yuan, Ti-Fei – sequence: 3 givenname: Jing-Xiang surname: Zhong fullname: Zhong, Jing-Xiang – sequence: 4 givenname: Yong surname: Ding fullname: Ding, Yong – sequence: 5 givenname: Kwok-Fai surname: So fullname: So, Kwok-Fai |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25429204$$D View this record in MEDLINE/PubMed |
BookMark | eNqNU02L2zAUNGVL96M99V4MhVIoSfVhyXYPhSXpx8JCD90eehKy_BQrlaVUshfy76skmzYJeygGWzzPjMfz3rvMzpx3kGUvMZoSXJTv5_P53fR7Scq6fJJdYFyWk6qq8NnB-Ty7jHGJEKecoGfZOWEFqQkqLrKfs877aNwiXwVQ1jijpM3jMLbrvPct2Jh7nbdGNjAYlYd0d34lh279If8F68TyjYU-5tqHXHkXTQtBDsa759lTLW2EFw_Pq-zH5093s6-T229fbmbXtxNVYjpMOK90BW3VNFVTS6oLgKKRpFAUK0QJUVS3rW4lZQRUxTXnXJFGKV0SxLis6VV2s9NtvVyKVTC9DGvhpRHbgg8LIUPybkFwrWqUtFTFZApAy4YxSoCVssRYMpq0Pu60VmPTQ6vADUHaI9HjN850YuHvRUEKgulGAO3N3ENKNMYTR_uq8r3AqQU4Ud4-fDP43yPEQfQmKrBWOvBjFJhThjCrt_b-B4oJLxP09Ql06cfgUiMEIbRiGPOK_UMtZIrHOO3TX6mNqLguEEY14wgl1PQRVLpa6E3qOWiT6keENweEDqQduujtuBmLeAx8dZj336z285kAeAdQwccYQAtlhu14JQvGCozEZgfEZgfEbgcS590JZy_7GPoPE9cHEg |
CitedBy_id | crossref_primary_10_3389_fphar_2021_811818 crossref_primary_10_7717_peerj_11316 crossref_primary_10_3892_mmr_2019_9863 crossref_primary_10_3390_antiox9060561 crossref_primary_10_3390_ijtm2010001 crossref_primary_10_2302_kjm_2021_0004_IR |
ContentType | Journal Article |
Copyright | COPYRIGHT 2014 Dove Medical Press Limited 2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Mi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 |
Copyright_xml | – notice: COPYRIGHT 2014 Dove Medical Press Limited – notice: 2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Mi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7RV 7XB 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH KB0 M2O MBDVC NAPCQ P64 PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.2147/DDDT.S72797 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library Nursing & Allied Health Database (Alumni Edition) Research Library Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Engineering Research Database MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1177-8881 |
EndPage | 2319 |
ExternalDocumentID | oai_doaj_org_article_6fc90fdac85a429fab5532e57a711a53 PMC4242133 oai_dovepress_com_19201 A401095600 25429204 10_2147_DDDT_S72797 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GeographicLocations | Spain Hong Kong China |
GeographicLocations_xml | – name: Spain – name: China – name: Hong Kong |
GroupedDBID | --- 0YH 29G 2WC 53G 5GY 5VS 7RV 8FI 8FJ 8G5 AAYXX ABUWG ACGFO ACIWK ACPRK ADBBV ADRAZ AENEX AFKRA AFRAH AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI C1A CCPQU CITATION DIK DWQXO E3Z EBD EMOBN F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HYE IAO IHR IHW INH INR IPNFZ ITC KQ8 M2O M48 MK0 M~E NAPCQ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RPM SV3 TDBHL TR2 UKHRP VDV CGR CUY CVF ECM EIF NPM PPXIY PMFND 3V. 7QO 7XB 8FD 8FK FR3 MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 - ADACO BBAFP LI0 5PM PUEGO |
ID | FETCH-LOGICAL-c713t-668f8ed8bb8b9a3f4ee4ba24c31c0322c3fddfda352ec86f666c2bccf72056a93 |
IEDL.DBID | M48 |
ISSN | 1177-8881 |
IngestDate | Wed Aug 27 01:07:04 EDT 2025 Thu Aug 21 14:34:40 EDT 2025 Mon Jan 18 10:57:31 EST 2021 Fri Jul 11 01:46:51 EDT 2025 Fri Jul 11 03:55:24 EDT 2025 Sat Jul 26 02:19:34 EDT 2025 Tue Jun 17 21:47:05 EDT 2025 Tue Jun 10 20:28:26 EDT 2025 Thu May 22 21:19:47 EDT 2025 Mon Jul 21 06:08:45 EDT 2025 Tue Jul 01 01:57:56 EDT 2025 Thu Apr 24 22:57:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | default |
Keywords | neurovascular dysfunction ex vivo culture animal model in vitro culture |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c713t-668f8ed8bb8b9a3f4ee4ba24c31c0322c3fddfda352ec86f666c2bccf72056a93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/DDDT.S72797 |
PMID | 25429204 |
PQID | 2238511685 |
PQPubID | 2046454 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6fc90fdac85a429fab5532e57a711a53 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4242133 dovepress_primary_oai_dovepress_com_19201 proquest_miscellaneous_1635015953 proquest_miscellaneous_1635011267 proquest_journals_2238511685 gale_infotracmisc_A401095600 gale_infotracacademiconefile_A401095600 gale_healthsolutions_A401095600 pubmed_primary_25429204 crossref_citationtrail_10_2147_DDDT_S72797 crossref_primary_10_2147_DDDT_S72797 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
PublicationTitle | Drug design, development and therapy |
PublicationTitleAlternate | Drug Des Devel Ther |
PublicationYear | 2014 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Press Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove Press – name: Dove Medical Press |
References | 24936248 - World J Diabetes. 2014 Jun 15;5(3):267-81 22915034 - Invest Ophthalmol Vis Sci. 2012 Sep;53(10):6488-94 17003462 - Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4638-45 22593752 - Front Neurol. 2012 May 11;3:75 11399456 - Comp Biochem Physiol B Biochem Mol Biol. 2001 Jun;129(2-3):243-9 8603874 - Invest Ophthalmol Vis Sci. 1996 Apr;37(5):898-905 21127484 - Nat Protoc. 2010 Dec;5(12):1903-10 2062510 - Ophthalmology. 1991 May;98(5 Suppl):741-56 25017009 - Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):527-35 24664757 - Adv Exp Med Biol. 2014;801:669-75 17365659 - Microcirculation. 2007 Jan;14(1):25-38 21635964 - Prog Retin Eye Res. 2011 Sep;30(5):343-58 880082 - Arch Ophthalmol. 1977 Jul;95(7):1215-20 21394065 - Retina. 2011 Apr;31(4):673-8 23786217 - J Biomed Sci. 2013;20:38 22553559 - Int J Ophthalmol. 2010;3(3):224-7 22212972 - Mayo Clin Proc. 2012 Jan;87(1):77-88 18442090 - Glia. 2008 Aug 1;56(10):1076-90 22911805 - PLoS One. 2012;7(7):e41511 23221078 - Invest Ophthalmol Vis Sci. 2013 Jan;54(1):574-84 13129861 - Ophthalmology. 2003 Sep;110(9):1677-82 21658386 - Exp Eye Res. 2011 Jul;93(1):108-13 8110701 - Br J Ophthalmol. 1994 Jan;78(1):54-60 25029255 - PLoS One. 2014;9(7):e102309 21192081 - J Comp Neurol. 2011 Feb 15;519(3):506-27 22302382 - Angiogenesis. 2012 Jun;15(2):171-85 8738706 - Graefes Arch Clin Exp Ophthalmol. 1996 Jun;234(6):388-98 11473058 - Diabetes. 2001 Aug;50(8):1938-42 24933041 - Prog Retin Eye Res. 2014 Sep;42:103-29 11729961 - Ital J Anat Embryol. 2001;106(2 Suppl 1):237-44 7742285 - Br J Ophthalmol. 1995 Apr;79(4):362-7 24809388 - Expert Opin Drug Saf. 2014 Jun;13(6):785-802 21307645 - Oxid Med Cell Longev. 2010 Nov-Dec;3(6):392-403 23716429 - Magn Reson Med. 2014 Apr;71(4):1526-30 22945600 - Doc Ophthalmol. 2012 Dec;125(3):235-47 23485060 - Clin Sci (Lond). 2013 Jul;125(1):1-17 20335444 - Dis Model Mech. 2010 May-Jun;3(5-6):343-53 21293735 - Mol Vis. 2011;17:300-8 22503301 - Ophthalmology. 2012 Aug;119(8):1679-84 16249509 - Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4281-7 24531025 - Am J Ophthalmol. 2014 May;157(5):960-70 20727883 - Exp Eye Res. 2010 Nov;91(5):670-5 15557466 - Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4543-53 22969284 - Clin Ophthalmol. 2012;6:1393-7 22402950 - Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):199-201 22044044 - Diabetes Technol Ther. 2012 Mar;14(3):257-63 24121991 - Angiogenesis. 2014 Jul;17(3):429-42 24286086 - J Diabetes Res. 2013;2013:106594 20070152 - Ultrastruct Pathol. 2010 Feb;34(1):35-41 22729438 - Invest Ophthalmol Vis Sci. 2012 Aug;53(8):4910-6 23790257 - Expert Opin Pharmacother. 2013 Sep;14(13):1829-38 18220619 - Curr Diabetes Rev. 2006 Feb;2(1):71-98 17267004 - Vision Res. 2007 Mar;47(5):612-23 4064731 - Curr Eye Res. 1985 Oct;4(10):1087-92 20829433 - Am J Pathol. 2010 Nov;177(5):2659-70 19729434 - J Am Soc Nephrol. 2009 Dec;20(12):2503-12 12586175 - Jpn J Ophthalmol. 2003 Jan-Feb;47(1):28-35 8529097 - Mol Med. 1995 Jan;1(2):182-93 18996116 - Exp Eye Res. 2009 Jan;88(1):106-12 14654976 - Int J Mol Med. 2004 Jan;13(1):87-92 25055729 - J Diabetes Complications. 2014 Nov-Dec;28(6):767-71 21750018 - Exp Biol Med (Maywood). 2011 Sep;236(9):1051-63 12875445 - J Am Vet Med Assoc. 2003 Jul 15;223(2):198-201 22897941 - Stem Cell Res Ther. 2012;3(4):31 23032068 - Int Immunopharmacol. 2012 Dec;14(4):606-12 7887849 - Arch Ophthalmol. 1995 Mar;113(3):352-4 9227268 - Exp Eye Res. 1997 Apr;64(4):505-17 19940532 - Ophthalmologica. 2010;224(4):243-6 25038518 - Prog Retin Eye Res. 2014 Nov;43:17-75 19238311 - Acta Diabetol. 2010 Mar;47(1):59-64 24457359 - Br J Ophthalmol. 2014 May;98(5):675-8 23766636 - Clin Interv Aging. 2013;8:467-83 7691433 - Brain Res Dev Brain Res. 1993 Aug 20;74(2):207-17 9721595 - Pharmacol Res. 1998 Aug;38(2):97-100 22610144 - Doc Ophthalmol. 2012 Aug;125(1):31-42 20655908 - Exp Eye Res. 2010 Oct;91(4):530-6 11110039 - J Ocul Pharmacol Ther. 2000 Oct;16(5):471-9 25097467 - Clin Proteomics. 2014 Jul 14;11(1):29 18235022 - Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42 23807371 - JAMA Ophthalmol. 2013 Aug;131(8):1033-40 1713023 - Am J Pathol. 1991 Jul;139(1):81-100 24503724 - Eye (Lond). 2014 Apr;28(4):367-80 20840523 - Wound Repair Regen. 2010 Sep-Oct;18(5):532-42 10420122 - Ophthalmic Res. 1999;31(5):367-77 17574431 - Pharmacol Res. 2007 Jun;55(6):498-510 20445540 - Nature. 2010 May 27;465(7297):487-91 21191444 - Clin Ophthalmol. 2010 Dec 08;4:1481-8 15977012 - Diabetologia. 2005 Aug;48(8):1663-8 |
References_xml | – reference: 7691433 - Brain Res Dev Brain Res. 1993 Aug 20;74(2):207-17 – reference: 24121991 - Angiogenesis. 2014 Jul;17(3):429-42 – reference: 23485060 - Clin Sci (Lond). 2013 Jul;125(1):1-17 – reference: 22945600 - Doc Ophthalmol. 2012 Dec;125(3):235-47 – reference: 23032068 - Int Immunopharmacol. 2012 Dec;14(4):606-12 – reference: 18220619 - Curr Diabetes Rev. 2006 Feb;2(1):71-98 – reference: 22915034 - Invest Ophthalmol Vis Sci. 2012 Sep;53(10):6488-94 – reference: 22553559 - Int J Ophthalmol. 2010;3(3):224-7 – reference: 11473058 - Diabetes. 2001 Aug;50(8):1938-42 – reference: 8603874 - Invest Ophthalmol Vis Sci. 1996 Apr;37(5):898-905 – reference: 20840523 - Wound Repair Regen. 2010 Sep-Oct;18(5):532-42 – reference: 22212972 - Mayo Clin Proc. 2012 Jan;87(1):77-88 – reference: 23716429 - Magn Reson Med. 2014 Apr;71(4):1526-30 – reference: 23786217 - J Biomed Sci. 2013;20:38 – reference: 8529097 - Mol Med. 1995 Jan;1(2):182-93 – reference: 22969284 - Clin Ophthalmol. 2012;6:1393-7 – reference: 22044044 - Diabetes Technol Ther. 2012 Mar;14(3):257-63 – reference: 9721595 - Pharmacol Res. 1998 Aug;38(2):97-100 – reference: 23221078 - Invest Ophthalmol Vis Sci. 2013 Jan;54(1):574-84 – reference: 11729961 - Ital J Anat Embryol. 2001;106(2 Suppl 1):237-44 – reference: 12586175 - Jpn J Ophthalmol. 2003 Jan-Feb;47(1):28-35 – reference: 1713023 - Am J Pathol. 1991 Jul;139(1):81-100 – reference: 24664757 - Adv Exp Med Biol. 2014;801:669-75 – reference: 22729438 - Invest Ophthalmol Vis Sci. 2012 Aug;53(8):4910-6 – reference: 24457359 - Br J Ophthalmol. 2014 May;98(5):675-8 – reference: 20070152 - Ultrastruct Pathol. 2010 Feb;34(1):35-41 – reference: 24933041 - Prog Retin Eye Res. 2014 Sep;42:103-29 – reference: 21658386 - Exp Eye Res. 2011 Jul;93(1):108-13 – reference: 20335444 - Dis Model Mech. 2010 May-Jun;3(5-6):343-53 – reference: 24809388 - Expert Opin Drug Saf. 2014 Jun;13(6):785-802 – reference: 11399456 - Comp Biochem Physiol B Biochem Mol Biol. 2001 Jun;129(2-3):243-9 – reference: 15557466 - Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4543-53 – reference: 24936248 - World J Diabetes. 2014 Jun 15;5(3):267-81 – reference: 23790257 - Expert Opin Pharmacother. 2013 Sep;14(13):1829-38 – reference: 24531025 - Am J Ophthalmol. 2014 May;157(5):960-70 – reference: 24503724 - Eye (Lond). 2014 Apr;28(4):367-80 – reference: 11110039 - J Ocul Pharmacol Ther. 2000 Oct;16(5):471-9 – reference: 18235022 - Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42 – reference: 10420122 - Ophthalmic Res. 1999;31(5):367-77 – reference: 21635964 - Prog Retin Eye Res. 2011 Sep;30(5):343-58 – reference: 17365659 - Microcirculation. 2007 Jan;14(1):25-38 – reference: 7887849 - Arch Ophthalmol. 1995 Mar;113(3):352-4 – reference: 25097467 - Clin Proteomics. 2014 Jul 14;11(1):29 – reference: 20655908 - Exp Eye Res. 2010 Oct;91(4):530-6 – reference: 19238311 - Acta Diabetol. 2010 Mar;47(1):59-64 – reference: 24286086 - J Diabetes Res. 2013;2013:106594 – reference: 21293735 - Mol Vis. 2011;17:300-8 – reference: 13129861 - Ophthalmology. 2003 Sep;110(9):1677-82 – reference: 16249509 - Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4281-7 – reference: 23807371 - JAMA Ophthalmol. 2013 Aug;131(8):1033-40 – reference: 23766636 - Clin Interv Aging. 2013;8:467-83 – reference: 12875445 - J Am Vet Med Assoc. 2003 Jul 15;223(2):198-201 – reference: 22593752 - Front Neurol. 2012 May 11;3:75 – reference: 21127484 - Nat Protoc. 2010 Dec;5(12):1903-10 – reference: 7742285 - Br J Ophthalmol. 1995 Apr;79(4):362-7 – reference: 17574431 - Pharmacol Res. 2007 Jun;55(6):498-510 – reference: 25017009 - Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):527-35 – reference: 15977012 - Diabetologia. 2005 Aug;48(8):1663-8 – reference: 21192081 - J Comp Neurol. 2011 Feb 15;519(3):506-27 – reference: 17003462 - Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4638-45 – reference: 25055729 - J Diabetes Complications. 2014 Nov-Dec;28(6):767-71 – reference: 22897941 - Stem Cell Res Ther. 2012;3(4):31 – reference: 25029255 - PLoS One. 2014;9(7):e102309 – reference: 22911805 - PLoS One. 2012;7(7):e41511 – reference: 22402950 - Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):199-201 – reference: 8110701 - Br J Ophthalmol. 1994 Jan;78(1):54-60 – reference: 21394065 - Retina. 2011 Apr;31(4):673-8 – reference: 2062510 - Ophthalmology. 1991 May;98(5 Suppl):741-56 – reference: 21191444 - Clin Ophthalmol. 2010 Dec 08;4:1481-8 – reference: 880082 - Arch Ophthalmol. 1977 Jul;95(7):1215-20 – reference: 18996116 - Exp Eye Res. 2009 Jan;88(1):106-12 – reference: 19940532 - Ophthalmologica. 2010;224(4):243-6 – reference: 21750018 - Exp Biol Med (Maywood). 2011 Sep;236(9):1051-63 – reference: 9227268 - Exp Eye Res. 1997 Apr;64(4):505-17 – reference: 20445540 - Nature. 2010 May 27;465(7297):487-91 – reference: 8738706 - Graefes Arch Clin Exp Ophthalmol. 1996 Jun;234(6):388-98 – reference: 25038518 - Prog Retin Eye Res. 2014 Nov;43:17-75 – reference: 18442090 - Glia. 2008 Aug 1;56(10):1076-90 – reference: 17267004 - Vision Res. 2007 Mar;47(5):612-23 – reference: 14654976 - Int J Mol Med. 2004 Jan;13(1):87-92 – reference: 20829433 - Am J Pathol. 2010 Nov;177(5):2659-70 – reference: 19729434 - J Am Soc Nephrol. 2009 Dec;20(12):2503-12 – reference: 4064731 - Curr Eye Res. 1985 Oct;4(10):1087-92 – reference: 22302382 - Angiogenesis. 2012 Jun;15(2):171-85 – reference: 22610144 - Doc Ophthalmol. 2012 Aug;125(1):31-42 – reference: 21307645 - Oxid Med Cell Longev. 2010 Nov-Dec;3(6):392-403 – reference: 20727883 - Exp Eye Res. 2010 Nov;91(5):670-5 – reference: 22503301 - Ophthalmology. 2012 Aug;119(8):1679-84 |
SSID | ssj0063620 |
Score | 2.0345452 |
SecondaryResourceType | review_article |
Snippet | Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a... Xue-Song Mi,1,2 Ti-Fei Yuan,3,4 Yong Ding,1 Jing-Xiang Zhong,1 Kwok-Fai So4,5 1Department of Ophthalmology, First Affiliated Hospital of Jinan University,... |
SourceID | doaj pubmedcentral dovepress proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2311 |
SubjectTerms | Angiogenesis animal model Animal models Animal models in research Animals Culture Design of experiments Design optimization Diabetes Diabetes mellitus Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 2 - complications Diabetic retinopathy Diabetic Retinopathy - complications Diabetic Retinopathy - drug therapy Disease Models, Animal Edema ex vivo culture Experimental design Eye surgery Humans Hyperglycemia Hypotheses in vitro culture In vivo methods and tests Medical imaging Medical research neurovascular dysfunction Pathogenesis Prevention Researchers Retina Retinopathy Review Tumor necrosis factor-TNF Vascular endothelial growth factor |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SF_VB_Ha1aoRSUbp0v5LN-lZ7liIoBa9Qn0I-aaHsinsV7r93Jtnd3qrQF1-TueMyM5n5JZf5DSE7lteQGJoyra0oU0DgLtWQClKmC8W50RA1sd75y1d-fFp9PmNnG62-8E1YpAeOitvn3jSZt8oIpiB2eqUZKwvHalXnuWKB5xNy3niYijGYQ1jOYlsViMFC5LEyD3vy7FtrYbdC2kaep41cFCj775LbtvsV36D-HaQ3stT8BeVGSjq6T-4NWJIexDU8ILdc-5DsnkQy6vUeXV7XVvV7dJeeXNNUrx-R74fnXYc3BRR-x1ggSQPdLA39cXraeRrvZi8MxWrHtsMGxusPFHY-HVrR9BRgLzVD389g58fk9OjT8vA4HRotpAbOqKuUc-GFs0JroRtV-sq5SquiMmVuMtjxpvTWgg0ArDkjuIcjjym0Mb4uAD-ppnxCttqudc8IRUjhtOdFA-aCo4pSouGVYA0MaUCTCXk_qlyagYUcm2FcSjiNoH3kYrFYym_BPgnZmYR_RPKNf4t9RNtNIsiYHQbAj-TgR_ImP0rIu8nyf3zTOAohQMISsjwhr9EzZCxVnWKEPKjwj0bEkAl5GyQwSsDyjBqKHUBJyLc1k9yeScLuNvPp0fvkEF16CZAOgTIXLCFvpmn8JL6Ya1131UvA2SzD-rD6JhnW4OqfRoeell7ERmZVQuqZq890M59pL84DP3mFzwzK8vn_MMsLcgcUXsVLr22ytfp55V4CDFzpV2HH_wa3WFym priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgewAeEN8EBhhpGgItrE1ix-EFbeumCYmpgk7anizbsdkklIylQ-p_z13spA0geLWvle3z3f18uQ9CNkueg2Eo0jgvRRoDArexBlMQM50ozo0GrYn5zp-P-dFJ9umUnQaHWxPCKjud2CrqsjboI98BM4bggAv28fJHjF2j8OtqaKFxk6yDChbw-FrfOzieful0MQf1PPJZediPZ2cymczefwWTjTWeVuxQW67_DrlV1j99_OmfCnrFQg2jJ1fM0eE9cjfgSLrrGX-f3LDVA7I19YWoF9t0tsyrarbpFp0uS1QvHpKz_fO6Ri8BhXV0yZG0LTVL2944Da0d9X7ZC0Mx07GqsXnx4gMFqaehDU1DAfJSE3p-tjx-RE4OD2b7R3FoshAbeJ_OY86FE7YUWgtdqNRl1mZaJZlJx2YE0m5SV5auVADUrBHcwXPHJNoYlyeAnVSRPiZrVV3Zp4QinLDa8aRgKoNnilKi4JlgBQxpQJIRedcduTShAjk2wvgu4SWC_JHIH-n5E5HNnvjSF974O9ke8q4nwWrZ7UB99U0G4ZPcmWIEezACFpYUTmnG0sSyXOXjsWJpRN72nP_tn7pRuIoStjAaR-QV3gzp01R7_SB3M_zIiPgxIm9aCtQQsD2jQqIDHBLW2hpQbgwoQbLNcLq7fTJolkYu5SAir_tp_CVGy1W2vm4kYGw2wtyw_H80rMDdP_EXut964puYZRHJB1d9cDbDmerivK1NnmGIQZo--_fSn5PbcJSZd2VtkLX51bV9AeBurl8GCf4F7mRSkg priority: 102 providerName: ProQuest |
Title | Choosing preclinical study models of diabetic retinopathy: key problems for consideration |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25429204 https://www.proquest.com/docview/2238511685 https://www.proquest.com/docview/1635011267 https://www.proquest.com/docview/1635015953 http://www.dovepress.com/getfile.php?fileID=22470 https://pubmed.ncbi.nlm.nih.gov/PMC4242133 https://doaj.org/article/6fc90fdac85a429fab5532e57a711a53 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3_a9QwFA9z-0H9QfxudZ4RxkRZ57VN0lQQ2XYbQ9g49A7mTyFJUzcYrd7dxPvvfa9pu3UO9NfktTTv6ydp3nuEbOQihcCQJWGayyQEBO5CA6Eg5CbWQlgDXhPznY-OxeGUfT7hJyukbcbZMHB-49YO-0lNZ-fbv38uP4HBf8RrzBFL349Go8n2VwjEWXqLrEFIStFCj1j3O0GAlx76LivgkqWMfKLe9Yd7oamu4H-X3M6rX_5K6t8--0rQ6l-ovBKhDu6Tew20pDteFx6QFVc-JJtjX5t6uUUnl6lW8y26SceXVauXj8i3vdOqwoMDCt_R5kvSuvosrdvlzGlVUH9Ue2YpJj-WFfYzXn6g4Aho05lmTgEFU9u0Aa3F_phMD_Yne4dh03chtLBlXYRCyEK6XBojTaaTgjnHjI6ZTSI7BAdgkyLPi1wDdnNWigJ2QDY21hZpDHBKZ8kTslpWpXtGKCIMZwoRZ1wz2LloLTPBJM9gyAC4DMi7luXKNkXJsTfGuYLNCcpHoXyUl09ANjriH74Wx81kuyi7jgQLaNcD1ey7auxRicJmQ1iDlfBhcVZow3kSO57qNIo0TwLytpP8tTe1o-ARFCxhGAXkFWqG8pmrnctQOwz_OyKkDMibmgLVGJZndZP7AEzC8ls9yvUeJRi77U-32qdaW1GA8BA3C8kD8rqbxifxAl3pqou5AtjNh5gulv6Lhme4-qdeobulx76vGQtI2lP1Hm_6M-XZaV2unOGtgyR5_n_Se0HuAEuZP-VaJ6uL2YV7CbhvYQZkbXf_ePxlUJ-bDGoL_wNuCFn1 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9N28PgAfFNYDAjjSHQwtp8OAkSQtu6qWNbVbFOGk_Gdhw2CSVj7UD9p_gbuYuTtAEET3u1r5XtO9_97PjuB7CW8ggDQ-K7URr7LiJw4yoMBW6oPMm5Vug1Kd_5aMD7J8GH0_B0AX7WuTD0rLL2iaWjTgtNd-SbGMYIHPA4fH_xzSXWKPq6WlNoWLM4MNMfeGQbv9vvoX5feN7e7min71asAq7GA9nE5TzOYpPGSsUqkX4WGBMo6QXa7-oOmrf2szTNUonIxOiYZ4jvtae0ziIPwYKk4kvo8pcCH48yi7C0vTsYfqx9P8dw0LFZgMT_s9nr9UZvjhEiUE2pubhX0gPchOW0-G7fu_4ZEOYiYvu15lz427sNtyrcyrasod2BBZPfhfWhLXw93WCjWR7XeIOts-GsJPb0HnzaOSsKupVgOI46GZOVpW1ZycUzZkXG7D3wuWaUWZkXRJY8fcvQy7CK9mbMEGIzXXGMljZ1H06uZfkfwGJe5OYRMIIvRmXcS0IZ4LFIyjjhQRwm2KQQuTrwul5yoauK50S88VXgyYf0I0g_wurHgbVG-MIW-vi72DbprhGh6txlQ3H5RVSbXfBMJx2cg45xYF6SSRWGvmfCSEbdrgx9B141mv_tn-pWNH2BU-h0HVglyxA2LbbxR2IroI-ahFcdeFlKkEfC6WlZJVbgIlFtr5bkSksSPYlud9fWJypPNhazfefA86abfkmv83JTXI0FYvqwQ7lo0f9kwoRm_9AadDN1z5KmBQ5ELVNvrU27Jz8_K2uhB_Skwfcf_3voq7DcHx0disP9wcETuIHLGthrtBVYnFxemacILCfqWbWbGXy-bgfyC45fkXk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTeLjAfFNYDAjjSHQQtMkdhIkhLZ11cagqkYnjSdjOw6bhJKxdKD-a_x13MVJ2gCCp73a18q-O9_97NwHIespj8AxJIEbpXHgAgI3rgJX4DLlS861AquJ-c4fRnzvKHx3zI6XyM8mFwbDKhubWBnqtND4Rt4DN4bggMesl9VhEePB8O3ZNxc7SOGX1qadhlWRAzP7Ade38s3-AGT9zPeHu5OdPbfuMOBquJxNXc7jLDZprFSsEhlkoTGhkn6og772QNV1kKVplkpAKUbHPAOsr32ldRb5ABwkFmIC878Swa3IWyYr27uj8WHjBzi4Bs9mBGIvoN5gMJi8-ghwAetLLfjAqlXAdXI1Lb7b2Nc_ncOCd-xGbi64wuFNcqPGsHTLKt0tsmTy22RjbItgzzbpZJ7TVW7SDTqel8ee3SGfdk6KAl8oKKyjScykVZlbWvXlKWmRUfsmfKopZlnmBTZOnr2mYHFo3QKnpAC3qa77jVb6dZccXQr775HlvMjNA0IRyhiVcT9hMoQrkpRxwsOYJTCkAMU65GXDcqHr6ufYhOOrgFsQykegfISVj0PWW-IzW_Tj72TbKLuWBCt1VwPF-RdRH3zBM514sAcdw8L8JJOKscA3LJJRvy9Z4JAXreR_-6dmFI6BgC14fYesoWYImyLb2iaxFeIHTsSuDnleUaB1gu1pWSdZAJOwzleHcrVDCVZFd6cb7RO1VSvF_Aw65Gk7jb_ESL3cFBelAHzPPMxLi_5HwxLc_X2r0O3WfdtALXRI1FH1Dm-6M_npSVUXPcTwhiB4-O-lr5ErYDjE-_3RwSNyDbga2he1VbI8Pb8wjwFjTtWT-jBT8vmy7ccvE3CVrg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Choosing+preclinical+study+models+of+diabetic+retinopathy%3A+key+problems+for+consideration&rft.jtitle=Drug+design%2C+development+and+therapy&rft.au=Mi%2C+Xuesong&rft.au=Yuan%2C+Ti-Fei&rft.au=Zhong%2C+Jing-Xiang&rft.au=Ding%2C+Yong&rft.date=2014-01-01&rft.issn=1177-8881&rft.eissn=1177-8881&rft.spage=2311&rft_id=info:doi/10.2147%2FDDDT.S72797&rft.externalDBID=n%2Fa&rft.externalDocID=10_2147_DDDT_S72797 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1177-8881&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1177-8881&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1177-8881&client=summon |